🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Single dose comparison of liquid and solid formulation, followed by study o...
Status
Completed
Location
Quotient Clinical
Start Date
2016-07
Trial ID
NCT02808741
Treatments Being Tested
Open label evaluation of a single intravenous dose of F901318 to healthy ma...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05
Trial ID
NCT03076905
Treatments Being Tested
A single oral dose study to investigate the PK and safety of olorofim in mi...
Status
Completed
Location
Orange County Research Centre
Start Date
2021-07-02
Trial ID
NCT04752540
Treatments Being Tested
Study of interactions between F901318 and multiple doses of posaconazole an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05
Trial ID
NCT03095547
Treatments Being Tested
A Phase I, open label study evaluating safety, tolerability and pharmacokin...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2017-12-12
Trial ID
NCT03340597
Treatments Being Tested
Non-randomized, multi-centre, open label, uncontrolled, multiple dose, phas...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-03
Trial ID
NCT03036046
Treatments Being Tested
Open label evaluation of potential interaction of F901318 with cytochrome P...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2016-01
Trial ID
NCT02680808
Treatments Being Tested
Double blind, placebo controlled, ascending single oral dose, sequential gr...
Status
Completed
Location
Simbec Orion
Start Date
2015-10
Trial ID
NCT02394483
This study assesses the pharmacokinetics and safety of the new antifungal F...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-04-20
Trial ID
NCT02856178
Treatments Being Tested
This is a Phase 1, single-centre, fixed-sequence, open label, drug-drug int...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2019-11-18
Trial ID
NCT04171739
Treatments Being Tested